Obesity Medicine through the Lifespan (Recorded Webinar)
This session will provide practical case based strategies for managing adolescent patients receiving GLP-1 medications, including nutritional priorities, adherence challenges, and real-world considerations in daily practice. Faculty will also address the identification and management of eating disorders in patients with obesity, review emerging GLP-1 therapies currently in development, discuss when genetic testing for monogenic obesity should be considered, and highlight evidence-based non-GLP-1 pharmacologic options for obesity treatment.
CME/CE Expiration Date: 5/15/29
*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.
Rushika Conroy, MD, MS, DABP, DABOM
Shilpi Relan MD, FAAP, DABOM
Available Credit
- 1.00 AMA PRA Category 1 Credit™The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Obesity Medicine Association designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the commensurate amount with the extent of their participation in the activity. - 1.00 Participation

Facebook
X
LinkedIn
Forward